Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion type Assertion NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_head.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion description "[Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Kr�ppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_provenance.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion evidence source_evidence_literature NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_provenance.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion SIO_000772 21075859 NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_provenance.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion wasDerivedFrom befree-2016 NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_provenance.
- NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_assertion wasGeneratedBy ECO_0000203 NP852351.RABGQRXMBW4qqFDfthq2F8n0OwZtBNDL0cQkWk8k29StY130_provenance.